Autor segons l'article: Siham Bouaouz; Rebeca Lozano; Francisca I. Bravo; Begoña Muguerza; Miquel Mulero; Enrique Calvo; Paula Ortega; F. Javier de la Mata
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.sciencedirect.com/science/article/pii/S1773224725013401?via%3Dihub
Departament: Bioquímica i Biotecnologia
Autor/s de la URV: Francisca I. Bravo; Begoña Muguerza; Miquel Mulero; Enrique Calvo
DOI de l'article: 10.1016/j.jddst.2025.107937
Resum: Multifunctional nanomaterials offers promising strategies for the treatment of skin disorders involving oxidative stress, microbial infections, and hyperpigmentation. Herein, we report the covalent functionalization of silver nanoparticles AgNP-(S-PEG2K-CA) (AgNP-1) with caffeic acid, a natural polyphenol with well-known antioxidant and anti-melanogenic properties. Additionally, a cationic carbosilane wedge was introduced to confer antibacterial functionality, resulting in a heterofunctional nanoconjugate, AgNP-(S-PEG2K-CA)(S-G1-NMe3Cl) (AgNP-2), with enhanced biological performance. The physicochemical characterization confirmed successful functionalization and stability of the nanoparticles. Biological assays showed that the silver nanoparticles exhibited antioxidant activity (AgNP-1: IC50 = 4.18 μg/mL, EC50 = 0.57 μg/mL; AgNP-2: IC50 = 12.35 μg/mL, EC50 = 0.87 μg/mL), which was attributed to the presence of caffeic acid on their surface and AgNP-2 exhibited strong antibacterial effects, particularly against Staphylococcus aureus (MIC 4 mgL−1 and MBC 8 mgL−1) and Escherichia coli (MIC 4 mgL−1 and MBC 8 mgL−1). In vitro experiments using a mammalian melanocyte model (B16F10 cells) revealed for both nanoparticles significantly inhibited melanin synthesis at 20 μg/mL reduced the accumulation of intracellular melanin in a similar extent as kojic acid at 1000 μg/mL. Finally, permeation studies using Franz diffusion cells, combined with UV–Vis spectroscopy and ICP-OES analysis to detect nanoparticle concentration, showed that neither AgNP-1 nor AgNP-2 were able to cross the membrane, indicating that they remain confined to the membrane surface. This localization is crucial for minimizing the risk of systemic exposure, thereby supporting the safety and suitability of these nanoparticles for topical applications.
Any de publicació de la revista: 2026
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: franciscaisabel.bravo@urv.cat
Tipus de publicació: info:eu-repo/semantics/article